Stockscreener 앱 받기
13.55
3.91%
0.51
전일 마감가:
$13.04
열려 있는:
$13.17
하루 거래량:
640.00K
Relative Volume:
0.96
시가총액:
$403.09M
수익:
$34.33M
순이익/손실:
$-23.14M
주가수익비율:
-16.40
EPS:
-0.8262
순현금흐름:
$-13.82M
1주 성능:
+0.67%
1개월 성능:
-6.36%
6개월 성능:
+13.67%
1년 성능:
-26.28%
1일 변동 폭
$13.13
$14.16
1주일 범위
$12.55
$14.42
52주 변동 폭
$9.76
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
명칭
Clearpoint Neuro Inc
전화
(949) 900-6833
주소
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
13.55 | 387.92M | 34.33M | -23.14M | -13.82M | -0.8262 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2023-10-24 | 개시 | Stifel | Buy |
| 2023-02-16 | 재개 | B. Riley Securities | Buy |
| 2022-04-05 | 재개 | B. Riley Securities | Buy |
| 2021-03-18 | 개시 | Lake Street | Buy |
| 2020-07-17 | 개시 | B. Riley FBR | Buy |
모두보기
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
Pullback Watch: What are ClearPoint Neuro Incs recent SEC filings showing2025 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
Is ClearPoint Neuro Inc. stock ready for breakoutJuly 2025 Action & Reliable Entry Point Alerts - mfd.ru
Is ClearPoint Neuro Inc. stock forming a cup and handle2025 Trade Ideas & Weekly Market Pulse Updates - mfd.ru
Essex Investment Management Co. LLC Sells 92,920 Shares of ClearPoint Neuro, Inc. $CLPT - MarketBeat
Published on: 2026-02-07 14:18:50 - baoquankhu1.vn
Aug Big Picture: What chart patterns are forming on Cavco Industries IncDividend Hike & Growth Focused Entry Reports - baoquankhu1.vn
Earnings Risk: What is GCTSWSs valuation compared to sectorQuarterly Growth Report & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Understanding the Setup: (CLPT) and Scalable Risk - Stock Traders Daily
US Market Wrap: What are ClearPoint Neuro Incs recent SEC filings showingQuarterly Trade Review & Growth Focused Entry Point Reports - baoquankhu1.vn
ClearPoint Neuro expands team to over 170 focused on Neuro - Traders Union
Painful Week for Individual Investors Invested in ClearPoint Neuro, Inc. (NASDAQ:CLPT) After 18% Drop, Institutions Also Suffered Losses - 富途牛牛
ClearPoint Neuro (NASDAQ:CLPT shareholders incur further losses as stock declines 18% this week, taking five-year losses to 47% - simplywall.st
Published on: 2026-01-30 00:59:02 - baoquankhu1.vn
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Is A 115.93% Upside On The Horizon? - DirectorsTalk Interviews
Insider Selling: ClearPoint Neuro (NASDAQ:CLPT) CEO Sells $45,822.51 in Stock - MarketBeat
CLPT Gets EU MDR Certification for ClearPoint Navigation Software - Finviz
ClearPoint Neuro: From Validation To Scale (NASDAQ:CLPT) - Seeking Alpha
Market Review: Can NextPlat Corp Equity Warrant outperform under higher oil pricesRisk Management & Growth Focused Investment Plans - baoquankhu1.vn
Quarterly Earnings: Will Georgia Power Company Preferred Security be affected by tariffsBreakout Watch & Growth Oriented Trade Recommendations - baoquankhu1.vn
The Technical Signals Behind (CLPT) That Institutions Follow - Stock Traders Daily
ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software - Sahm
ClearPoint Neuro receives EU MDR certification for navigation software By Investing.com - Investing.com Australia
ClearPoint Neuro stock rises after receiving EU MDR certification By Investing.com - Investing.com South Africa
ClearPoint Neuro stock rises after receiving EU MDR certification - Investing.com
ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe - BioSpace
ClearPoint Neuro receives EU MDR certification for navigation software - Investing.com
New brain surgery software opens CT-guided option for hospitals without MRI - Stock Titan
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Navigating a 107% Potential Upside with Analyst Confidence - DirectorsTalk Interviews
While institutions own 40% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 52% ownership - Yahoo Finance
Aug Volume: Is ClearPoint Neuro Inc stock forming a cup and handle2025 Stock Rankings & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Published on: 2026-01-16 07:23:49 - baoquankhu1.vn
Precision Trading with Clearpoint Neuro, Inc. (CLPT) Risk Zones - Stock Traders Daily
ClearPoint Neuro (NASDAQ:CLPT) CEO Sells $322,400.00 in Stock - MarketBeat
Earnings Risk: Will ClearPoint Neuro Inc stock deliver better than expected guidance2025 Valuation Update & Long-Term Growth Portfolio Plans - Bộ Nội Vụ
ClearPoint Neuro reports 20% sales growth in Q4 2025 By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) Reports Strong Preliminary Revenue Growt - GuruFocus
CLPT Forecasts Strong Revenue Growth by 2026 - GuruFocus
ClearPoint Neuro sees Q4 revenue $10.4M, up 20% y/y - TipRanks
ClearPoint Neuro (CLPT) Reports Strong Q4 2025 Revenue Growth - GuruFocus
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue - morningsun.net
ClearPoint Neuro prelim Q4 revenue rises - TradingView
How ClearPoint Neuro Inc. stock benefits from tech adoption2025 Top Decliners & High Return Trade Opportunity Guides - ulpravda.ru
Is ClearPoint Neuro Inc. stock attractive after correctionJuly 2025 Trade Ideas & Weekly High Conviction Ideas - Улправда
ClearPoint Neuro restructures IRRAS subsidiary under debt agreement - MSN
Will ClearPoint Neuro Inc. stock attract ESG investors2025 Analyst Calls & Fast Gaining Stock Reports - ulpravda.ru
Clearpoint Neuro Inc (CLPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.51%
자본화:
|
볼륨(24시간):